Who is sponsoring TABAGERM?

TABAGERM is sponsored by University Hospital, Toulouse.

What condition does TABAGERM study?

TABAGERM studies Male Infertility.

What drugs are being tested in TABAGERM?

Interventions: Fragmented DNA evaluation in blood and semen samples.

What is the status of TABAGERM?

TABAGERM is currently COMPLETED.

Last reviewed 2022-07-19 · How we verify

Tobacco and Sperm Genome: Effects of Smoking Cessation (TABAGERM)

NCT03552081 NA COMPLETED

Tobacco is a male infertility risk factor. Many studies comparing smokers to non-smokers have shown effects on spermatogenesis and the quality of the male gamete. In vitro fertilization success rates are decreased in smokers and in natural procreation the time required to conceive (excellent fertility indicator) seems to be lengthened in the smoker. The prospective study that the investigators propose to carry out would make it possible to know the time required for the repair of the sperm abnormalities and in particular the DNA of the gametes generated by the smoking.

Details

Lead sponsor	University Hospital, Toulouse
Phase	NA
Status	COMPLETED
Enrolment	25
Start date	Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Male Infertility

Interventions

Fragmented DNA evaluation in blood and semen samples

Countries

France